Research body launches tender for advanced genomics lab kit
New contract notice seeks suppliers for sequencing, PCR and core lab systems, underlining continued investment in high-capacity life science research.
New contract notice seeks suppliers for sequencing, PCR and core lab systems, underlining continued investment in high-capacity life science research.
Follow Tenderlake on LinkedIn for concise insights on public-sector tenders and emerging procurement signals.
Associação BIOPOLIS has launched a tender for a package of next generation sequencing, PCR and core laboratory systems, underlining growing investment in life science infrastructure across the region.
On 15th May 2026, Associação BIOPOLIS published a contract notice titled Laboratory Equipment Acquisition. The buyer is seeking the supply, delivery and installation of a broad suite of laboratory equipment, combining high-end genomics tools with core instruments needed for day-to-day experimental work.
The summary specifies the following categories of equipment:
This mix brings together sequencing tools, PCR platforms, analytical instruments and the sample preparation infrastructure that links them. Grouping these items in a single procurement is consistent with equipping an integrated laboratory rather than purchasing a single flagship instrument. The notice extract, however, does not reveal the number of lots, the planned configuration of the lab, or the specific scientific fields that will use the equipment.
The Associação BIOPOLIS tender sits within a wider wave of public procurements focused on next generation sequencing, PCR and related technologies across research and clinical settings.
In November 2025, SPITALUL CLINIC JUDETEAN DE URGENTA SF. APOSTOL ANDREI issued a contract notice for Medical Equipment Supply and Installation, covering Real Time PCR equipment and a complete Sanger sequencing system for its Pathological Anatomy and Medical Genetics Laboratory. The hospital aims to improve oncological diagnosis and align its services with modern medical standards.
A month later, in December 2025, Latvijas Universitāte went to market with a Laboratory Equipment Acquisition focused on establishing a genomics platform. The notice details systems for genetic analysis, real-time PCR, digital PCR, visualisation and a range of supporting laboratory devices.
That momentum continues into 2026. In January 2026, Śląski Uniwersytet Medyczny w Katowicach published a notice for Control and Research Equipment Delivery, combining multi-module analysers for RT-PCR testing, modern diagnostic instruments such as QTOF mass spectrometers and liquid chromatographs, and systems for automatic DNA and RNA isolation and purification.
In March 2026, UNIVERZITETNI KLINIČNI CENTER LJUBLJANA launched a tender for the Purchase of NGS Sequencing Equipment, while in the same month Valsts sabiedrība ar ierobežotu atbildību "Bērnu klīniskā universitātes slimnīca" sought Next Generation Sequencing Equipment together with technical maintenance services. Next generation sequencing is now firmly embedded in equipment plans for hospitals and specialist centres, not just research institutes.
Beyond clinical genomics, sequencing is also reaching other applied research domains. In February 2026, Instituto Português do Mar e da Atmosfera, IP, published a notice on Nucleic Acid Sequencing Equipment. On the same month, Food4Sustainability - Associação para a Inovação no Alimento Sustentável launched a tender for NGS Reagents and Consumables, including installation and maintenance services, while in March 2026 Aristoteleio Panepistimio Thessalonikis set out a contract for the Supply and Installation of Scientific Equipment for its Department of Biology, including a next generation sequencing platform, thermal cyclers and microscopes.
Many recent procurements move beyond single flagship instruments to cover the wider environment needed to run modern laboratories. The Associação BIOPOLIS tender, which combines sequencing tools, PCR systems and core analytical equipment, fits that pattern.
In December 2025, Landeslabor Berlin-Brandenburg issued a tender for the Laboratory Equipment Procurement of various instruments for sample preparation related to next generation sequencing, split into eight different lots. The focus on dedicated sample preparation equipment highlights that investment is not confined to sequencers alone.
For the Institute of Applied Biosciences, Ethniko Kentro Erevnas kai Technologikis Anaptyxis (E.K.E.T.A.) published, in December 2025, a contract notice titled Supply of Research Analytical Equipment. It covers a thermal circulator, genotyping and sequencing support equipment, an inverted trinocular fluorescence microscope, sample processing and preservation equipment, and liquid nitrogen tanks across multiple departments.
In April 2026, Eidikos Logariasmos Kondylion Erevnas Panepistimiou Thessalias set out an even broader Laboratory Equipment Procurement, ranging from automated liquid management systems, molecular analysis systems and genomic analysis systems to computer infrastructure, microscopy tools, biosafety equipment, bioreactors, basic lab equipment and oligonucleotide production systems.
Other buyers are pairing hardware with explicit service elements. HCEMM Nonprofit Korlátolt Felelősségű Társaság, for example, is running a General Laboratory Equipment Procurement for autoclaves, centrifuges, microscopes and pipettes, requiring delivery, installation, functional testing and training for the contracting authority.
Nemzeti Biodiverzitás- és Génmegőrzési Központ is taking a similar approach. In March 2026 it published a Laboratory Equipment Acquisition covering freezers, fume hoods, safety cabinets and other items for the National Biodiversity and Gene Conservation Center, with requirements for new equipment, installation and training.
By contrast, the Associação BIOPOLIS summary is concise. It lists the main technology families and requires supply, delivery and installation, but does not describe lots, commissioning arrangements or follow-on support. Even without that extra detail, the inclusion of both next generation sequencing tools and core instruments indicates a multifaceted upgrade rather than a single-device purchase.
Several recent notices also stress reagents, consumables and long-term operation of new platforms, showing how, in these cases, equipment and running costs are being considered together.
In April 2026, ONCOMED SRL launched a contract for the Supply of Molecular Biology Equipment, reagents and consumables across six lots to support the establishment and operationalisation of a National Center of Competence in the field of Cancer.
Medusa Laboratories has taken a similar route. Its February 2026 notice for the Procurement of Laboratory Equipment and Consumables combines cosmetic laboratory equipment, sequencing and library preparation kits, and general laboratory consumables for microbiology and fermentation.
The Food4Sustainability - Associação para a Inovação no Alimento Sustentável tender for NGS Reagents and Consumables, published in February 2026, explicitly includes installation and maintenance services alongside supplies for next generation sequencing. Taken together, these examples show that at least some buyers now frame equipment procurement alongside reagents and technical support, bundling them into a single competition.
For Associação BIOPOLIS, the available notice text refers only to the supply, delivery and installation of instruments; it does not indicate whether reagents, consumables or maintenance will be procured within the same contract or through separate arrangements.
As buyers across the region publish tenders for sequencing platforms, PCR systems and supporting lab infrastructure, suppliers face a market in which requirements are broadening as well as deepening. Some organisations want individual sequencers or analysers; others, such as Associação BIOPOLIS, are looking for packages that combine multiple instruments along the laboratory workflow.
The series of notices outlined here, spanning hospitals, universities, research centres and specialist institutes, shows that investment in laboratory capacity is currently strong across multiple sectors. The outcome of Associação BIOPOLIS’s Laboratory Equipment Acquisition will offer another indication of how research-focused buyers are specifying advanced, multi-instrument laboratories in the current cycle of equipment upgrades.
Follow Tenderlake on LinkedIn for concise insights on public-sector tenders and emerging procurement signals.